4.8 Letter

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD

Simeng Wang et al.

Summary: Studies using mice lacking CB-1 in hepatocytes or stellate cells suggest that CB-1 signaling does not directly contribute to the development of NAFLD or liver fibrosis.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism

Isabel Gonzalez-Mariscal et al.

SCIENTIFIC REPORTS (2016)

Article Multidisciplinary Sciences

Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase

Jie Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)